Afexa Life Sciences Inc. (FXA-T) Stock Predictions - Stockchase
WATCH LIST
7
Afexa Life Sciences Inc. (FXA-T)

ON STOCKCHASE SINCE Dec 2004

Went private

biotechnology/pharmaceutical

Afexa Life Sciences Inc.

FXA-T

7 watching          
Join the Discussion

Afexa Life Sciences Inc. (FXA-T) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about FXA-T



  • All
  • Filtered
Signal Opinion Expert
COMMENT
A marketing company. A little bit of controversy. Want to label their product in the US. Never enthralled with marketing companies. Costs a lot of money and you are at the mercy of the vagueness of the consumer.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
A marketing company. A little bit of controversy. Want to label their product in the US. Never enthralled with marketing companies. Costs a lot of money and you are at the mercy of the vagueness of the consumer.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$2.490
Owned Owned
No

HOLD
Manufactures ColdFX. Loves the product, but a little concerned about the share price. Revenues are considerably smaller than the market cap. A little ahead of itself.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Manufactures ColdFX. Loves the product, but a little concerned about the share price. Revenues are considerably smaller than the market cap. A little ahead of itself.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Michael Decter

President , Lawrence Decter Inve...

Price Price
$2.400
Owned Owned
No

DON'T BUY
Started launching ColdFX in the US and want to go through the full trial process to get approval as to what they can claim on the product. Expensive stock.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Started launching ColdFX in the US and want to go through the full trial process to get approval as to what they can claim on the product. Expensive stock.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$2.810
Owned Owned
No

BUY
Had a long drop from December to May which was followed by a number of upward steps. Those are very important levels and he thinks the stock probably has more positive news in it. Every time there is a rally, there is a lot of volume with it.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Had a long drop from December to May which was followed by a number of upward steps. Those are very important levels and he thinks the stock probably has more positive news in it. Every time there is a rally, there is a lot of volume with it.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jeff Parent B.

VP & Portf, Castlemoore Inc....

Price Price
$3.980
Owned Owned
No

DON'T BUY
Great product. Watch for fads. Great marketing company.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Great product. Watch for fads. Great marketing company.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$2.840
Owned Owned
No

WATCH
A very interesting company. Using ginseng extract to create a remedy for colds. (ColdFX) The product has just taken off. Still looking at it. If they go into the US, it could be a big boost. Might be a little expensive here.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
A very interesting company. Using ginseng extract to create a remedy for colds. (ColdFX) The product has just taken off. Still looking at it. If they go into the US, it could be a big boost. Might be a little expensive here.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jean-Francois T

Senior Por, Sprott Asset Managem...

Price Price
$2.630
Owned Owned
No

DON'T BUY
Stock has had a huge run. Huge growth opportunity.Product ColdFX seems to be working very well. Negative is that it is trading at about 31 X sales. Very high risk.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Stock has had a huge run. Huge growth opportunity.Product ColdFX seems to be working very well. Negative is that it is trading at about 31 X sales. Very high risk.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$2.510
Owned Owned
No

Showing 1 to 7 of 7 entries
Successfully Saved Company
Successfully Saved Company